SIRT3 and glioblastoma: Inhibiting SIRT3 expression and activity in GBM cells increases their sensitivity to RSL3-induced ferroptosis both in vitro and in vivo, suggesting that targeting SIRT3 could enhance ferroptosis in GBM [90].